Tag: opioid

August 17, 2018

Cannabis Weekly Round-Up: Ontario Cannabis Shops Arriving in 2019

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
August 3, 2018

Cannabis Weekly Round-Up: HEXO Gets Partnership with Alcohol Producer

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
July 13, 2018

Weekly Round-Up: New Deal Splits Hiku-WeedMD Merger

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
June 29, 2018

Cannabis Weekly Round-Up: Manitoba Awards New Supply Agreements

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
June 15, 2018

Cannabis Weekly Round-Up: The Amendment Fight for Bill C-45

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
June 1, 2018

Cannabis Weekly Round-Up: Lift Cannabis Expo Takes Charge

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
May 9, 2018

Opiant Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results and Provides Corporate Update

Opiant Pharmaceuticals (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today reported financial results for the first quarter...
May 9, 2018

INSYS Therapeutics Announces Exclusive License Partnership with Lunatus to Commercialize SUBSYS® (fentanyl sublingual spray) in the Middle East

INSYS Therapeutics (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, announced today that...
May 8, 2018

MediciNova Announces Plans to Collaborate with UCLA Researchers in Grant-Funded Clinical Trial of MN-166 in Alcohol Use Disorder and Withdrawal

MediciNova a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange...